General Information of Drug (ID: DM8E54P)

Drug Name
BUTEIN Drug Info
Synonyms
butein; 487-52-5; 2',3,4,4'-Tetrahydroxychalcone; 3,4,2',4'-Tetrahydroxychalcone; 2',4',3,4-Tetrahydroxychalcone; UNII-4WVS5M0LGF; EINECS 207-659-5; 4WVS5M0LGF; (E)-1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)prop-2-en-1-one; CHEMBL128000; CHEBI:3237; (2E)-1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)prop-2-en-1-one; 1-(2,4-Dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-2-propen-1-one; ,3,4-Tetrahydroxychalcone; Chalcone, 2',3,4,4'-tetrahydroxy- (7CI,8CI); Acrylophenone, 2',4'-dihydroxy-3-(3,4-dihy
Cross-matching ID
PubChem CID
5281222
ChEBI ID
CHEMBL128000
CAS Number
CAS 487-52-5
TTD Drug ID
D0EW3L

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Ferroptosis 2.75 0.00e+0 36/41 (87.8%) HMOX1;SLC7A11;GCLM;...
Protein processing in endoplasmic reticulum 2.32 0.00e+0 127/171 (74.27%) HSPA1A;HSPA6;HERPUD1;...
Porphyrin and chlorophyll metabolism 2.22 0.00e+0 23/43 (53.49%) HMOX1;BLVRB;ALAS1;...
Antigen processing and presentation 2.16 0.00e+0 60/78 (76.92%) HSPA1A;HSPA6;HSPA8;...
Mineral absorption 2.16 0.00e+0 48/60 (80%) HMOX1;FTH1;STEAP1;...
Glutathione metabolism 2.07 0.00e+0 43/57 (75.44%) GCLM;CHAC1;PGD;...
Legionellosis 1.84 2.72e-2 51/57 (89.47%) HSPA1A;HSPA6;CXCL8;...
Metabolism of xenobiotics by cytochrome P450 1.81 3.10e-2 49/77 (63.64%) AKR1C1;ALDH3A1;EPHX1;...
Fluid shear stress and atherosclerosis 1.78 3.18e-2 123/139 (88.49%) HMOX1;SQSTM1;KEAP1;...
Protein export 1.76 3.62e-2 17/23 (73.91%) HSPA5;SRPRA;SEC62;...
Folate biosynthesis 1.73 4.33e-2 23/26 (88.46%) AKR1B10;AKR1C3;CBR1;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone
Osteosarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
U-2 OS CVCL_0042 Homo sapiens 10uM 6H
Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 10uM 6H, 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 10uM 6H
Hematopoietic system
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
ASC CVCL_U602 Homo sapiens 10uM 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 10uM 6H, 24H
Liver
Hepatoblastoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Hep G2 CVCL_0027 Homo sapiens 10uM 6H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 10uM 6H, 24H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HCC515 CVCL_5134 Homo sapiens 10uM 6H, 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 10uM 6H, 24H
VCaP CVCL_2235 Homo sapiens 10uM 6H, 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 10uM 6H